Results 31 to 40 of about 2,696,936 (253)

Acute infections and venous thromboembolism. [PDF]

open access: yes, 2011
BACKGROUND: Data on the association between acute infections and venous thromboembolism (VTE) are sparse. We examined whether various hospital-diagnosed infections or infections treated in the community increase the risk of VTE.
Horvath-Puho, E   +9 more
core   +1 more source

Risk stratification and contributing factors of deep vein thrombosis among patients admitted at Debre Markos comprehensive specialized hospital, Ethiopia in 2024

open access: yesFrontiers in Medicine
IntroductionDeep vein thrombosis is a serious condition and a leading cause of morbidity and mortality in hospitalized patients. Studies conducted in various hospitals in Ethiopia have reported that the prevalence rates of deep vein thrombosis range from
Haymanot Zeleke Mitiku   +5 more
doaj   +1 more source

Endovascular treatment of iliofemoral deep vein thrombosis in pregnancy using US-guided percutaneous aspiration thrombectomy [PDF]

open access: yes, 2017
PURPOSE We aimed to describe ultrasonography (US)-guided percutaneous aspiration thrombectomy in pregnant women with iliofemoral deep vein thrombosis.
Levent Oguzkurt   +3 more
core   +1 more source

The Incidence of Deep Vein Thrombosis after Hip and Knee Arthroplasties in Japanese Patients: A Prospective Study

open access: yesJournal of Orthopaedic Surgery, 2003
Purpose. To document the incidence of proximal deep vein thrombosis and pulmonary embolism in 58 consecutive Japanese patients undergoing total hip arthroplasty or total knee arthroplasty. Methods.
A Sudo   +5 more
doaj   +1 more source

Hospital admissions due to diseases of arteries and veins peaked at physiological equivalent temperature −10 to 10 °C in Germany in 2009–2011 [PDF]

open access: yes, 2015
We aimed to understand relationships of the weather as biometeorological and hospital admissions due to diseases of arteries and veins by subtypes, which have been scarcely studied, in a national setting in recent years. This is an ecological study.
Shiue, Ivy   +5 more
core   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa   +7 more
wiley   +1 more source

Massive DVT from the proximal IVC to the pedal vein: Our approach using aspiration mechanical thrombectomy and open surgery thrombectomy

open access: yesRadiology Case Reports, 2023
Deep venous thrombosis might present in an acute condition requiring early thrombus removal. Several endovascular and surgical approaches are available with a short treatment time and minimal complications compared to pharmacotherapies. However, due to a
Jacub Pandelaki, MD, PhD   +8 more
doaj   +1 more source

Dimerized plasmin fragment D as a potential biomarker to predict successful catheter-directed thrombolysis therapy in acute deep vein thrombosis

open access: yes, 2017
Objectives The value of dimerized plasmin fragment D in the clinical monitoring during the catheter-directed thrombolysis in patients with acute deep vein thrombosis is not known.
Luo, Chien-Ming;Wu, I-Hui;Chan, Chih-Yang;Chen, Yih-Sharng;Yang, Wei-Shiung;Wang, Shoei-Shen   +1 more
core   +1 more source

Improving the diagnostic workup of deep vein thrombosis: Findings from the Ri-Schedule study

open access: yes, 2022
In the Rivaroxaban for Scheduled Workup of Deep Vein Thrombosis (the Ri-Schedule) study, we identified patients with suspected deep vein thrombosis (DVT) of the leg in whom diagnostic workup could be deferred while receiving empiric anticoagulation ...
Vikum, Synne Frønæs
core   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy